Joseph A. Lasky, MD, School of Medicine
Dr. Lasky’s main clinical and research interest is the study of pulmonary fibrosis (lung scarring). Dr. Lasky is an author on over 125 publications pertaining to pulmonary fibrosis, which span basic molecular science to clinical trials. He has been engaged in designing, conducting, and monitoring clinical lung studies, and has been involved in writing medical society guidelines for the care of patients with lung fibrosis. He serves as the Site Principal Investigator for numerous ongoing trials that aim to improve upon care for patients with pulmonary fibrosis.
-A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GBT440 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Effect on Hypoxemia
-A Novel Method to Assess and Monitor Drug Efficacy for Pulmonary Fibrosis
